Pricing Log in Create free account

Clearmind Medicine Inc. (CMND) vs Jupiter Neurosciences, Inc. (JUNS)

Clearmind Medicine Inc. and Jupiter Neurosciences, Inc. are both Biotechnology companies. Clearmind Medicine Inc. and Jupiter Neurosciences, Inc. are of similar size ($3.0M and $2.8M). Across the 9 metrics below, Jupiter Neurosciences, Inc. leads on 5 and Clearmind Medicine Inc. on 4.

Valuation

Metric CMND JUNS Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.08 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.48 0.01 0.66
EV/Sales n/m n/m 9.02
Earnings yield (13,692.68%) (842.19%) (32.88%)
Free cash flow yield (661.85%) (572.73%) (23.13%)

Profitability

Metric CMND JUNS Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (106.98%) (1,888.80%) (51.96%)
Return on assets (71.81%) (239.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMND JUNS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 55.10% (212.50%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CMND JUNS Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 4.31 0.66 4.97
Net debt to EBITDA 0.68 0.43 1.01

Dividend

Metric CMND JUNS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMND JUNS Biotechnology median
Market cap 2.96m 2.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack